BRAF mutations were detected in 52% and RAS mutations in 28% of melanomas, and BRAF and RAS mutations were mutually exclusive, meaning that collectively, BRAF and RAS mutations were detected in more than 80% of melanomas16. This evidence concerns the gene BRAF and melanoma.